334 related articles for article (PubMed ID: 28128476)
1. Dementia, cognitive impairment and proton pump inhibitor therapy: A systematic review.
Batchelor R; Gilmartin JF; Kemp W; Hopper I; Liew D
J Gastroenterol Hepatol; 2017 Aug; 32(8):1426-1435. PubMed ID: 28128476
[TBL] [Abstract][Full Text] [Related]
2. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline.
Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D
Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266
[TBL] [Abstract][Full Text] [Related]
3. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
Freedberg DE; Kim LS; Yang YX
Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
[TBL] [Abstract][Full Text] [Related]
4. Time-Varying Use of Proton Pump Inhibitors and Cognitive Impairment and Dementia: A Real-World Analysis from Germany.
Ahn N; Wawro N; Baumeister SE; Nolde M; Gerlach R; Tauscher M; Günter A; Güntner F; Rückert-Eheberg IM; Meisinger C; Linseisen J
Drugs Aging; 2023 Jul; 40(7):653-663. PubMed ID: 37178361
[TBL] [Abstract][Full Text] [Related]
5. Do proton pump inhibitors increase the risk of dementia? A systematic review, meta-analysis and bias analysis.
Ahn N; Nolde M; Krause E; Güntner F; Günter A; Tauscher M; Gerlach R; Meisinger C; Linseisen J; Baumeister SE; Rückert-Eheberg IM
Br J Clin Pharmacol; 2023 Feb; 89(2):602-616. PubMed ID: 36331350
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitor use does not increase dementia and Alzheimer's disease risk: An updated meta-analysis of published studies involving 642305 patients.
Song YQ; Li Y; Zhang SL; Gao J; Feng SY
PLoS One; 2019; 14(7):e0219213. PubMed ID: 31265473
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor use and risk of dementia: Systematic review and meta-analysis.
Li M; Luo Z; Yu S; Tang Z
Medicine (Baltimore); 2019 Feb; 98(7):e14422. PubMed ID: 30762748
[TBL] [Abstract][Full Text] [Related]
8. Meta-analyses: does long-term PPI use increase the risk of gastric premalignant lesions?
Eslami L; Nasseri-Moghaddam S
Arch Iran Med; 2013 Aug; 16(8):449-58. PubMed ID: 23906249
[TBL] [Abstract][Full Text] [Related]
9. Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.
Gomm W; von Holt K; Thomé F; Broich K; Maier W; Fink A; Doblhammer G; Haenisch B
JAMA Neurol; 2016 Apr; 73(4):410-6. PubMed ID: 26882076
[TBL] [Abstract][Full Text] [Related]
10. No association between proton pump inhibitor use and risk of dementia: Evidence from a meta-analysis.
Hussain S; Singh A; Zameer S; Jamali MC; Baxi H; Rahman SO; Alam M; Altamish M; Singh AK; Anil D; Hussain MS; Ahmad A; Najmi AK
J Gastroenterol Hepatol; 2020 Jan; 35(1):19-28. PubMed ID: 31334885
[TBL] [Abstract][Full Text] [Related]
11. Systematic review with meta-analysis: risk of adverse cardiovascular events with proton pump inhibitors independent of clopidogrel.
Batchelor R; Kumar R; Gilmartin-Thomas JFM; Hopper I; Kemp W; Liew D
Aliment Pharmacol Ther; 2018 Oct; 48(8):780-796. PubMed ID: 30178881
[TBL] [Abstract][Full Text] [Related]
12. The Uncertainty of the Association Between Proton Pump Inhibitor Use and the Risk of Dementia: Prescription Sequence Symmetry Analysis Using a Korean Healthcare Database Between 2002 and 2013.
Park SK; Baek YH; Pratt N; Kalisch Ellett L; Shin JY
Drug Saf; 2018 Jun; 41(6):615-624. PubMed ID: 29397553
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors do not increase the risk of dementia: a systematic review and meta-analysis of prospective studies.
Desai M; Nutalapati V; Srinivasan S; Fathallah J; Dasari C; Chandrasekhar VT; Mohammad B; Kohli D; Vaezi M; Katz PO; Sharma P
Dis Esophagus; 2020 Oct; 33(10):. PubMed ID: 32476013
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitors and dementia risk: Evidence from a cohort study using linked routinely collected national health data in Wales, UK.
Cooksey R; Kennedy J; Dennis MS; Escott-Price V; Lyons RA; Seaborne M; Brophy S
PLoS One; 2020; 15(9):e0237676. PubMed ID: 32946449
[TBL] [Abstract][Full Text] [Related]
15. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review.
Melloni C; Washam JB; Jones WS; Halim SA; Hasselblad V; Mayer SB; Heidenfelder BL; Dolor RJ
Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):47-55. PubMed ID: 25587094
[TBL] [Abstract][Full Text] [Related]
16. Association of Proton Pump Inhibitor Use With Incident Dementia and Cognitive Decline in Older Adults: A Prospective Cohort Study.
Mehta RS; Kochar B; Zhou Z; Broder JC; Chung P; Yang K; Lockery J; Fravel M; Ryan J; Mahady S; Orchard SG; McNeil JJ; Murray A; Woods RL; Ernst ME; Chan AT
Gastroenterology; 2023 Sep; 165(3):564-572.e1. PubMed ID: 37315867
[TBL] [Abstract][Full Text] [Related]
17. Coronary heart disease and risk for cognitive impairment or dementia: Systematic review and meta-analysis.
Deckers K; Schievink SHJ; Rodriquez MMF; van Oostenbrugge RJ; van Boxtel MPJ; Verhey FRJ; Köhler S
PLoS One; 2017; 12(9):e0184244. PubMed ID: 28886155
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
19. Emulating a target trial of proton pump inhibitors and dementia risk using claims data.
Ahn N; Nolde M; Günter A; Güntner F; Gerlach R; Tauscher M; Amann U; Linseisen J; Meisinger C; Rückert-Eheberg IM; Baumeister SE
Eur J Neurol; 2022 May; 29(5):1335-1343. PubMed ID: 35170158
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
